enabling applications in food, feed, dietary supplements, and health ingredients for humans and animals. Bactolife’s innovations aim to reduce the risk of gastrointestinal infections and decrease reliance on traditional antibiotics by offering alternative mechanisms that strengthen the microbiome. The company collaborates with partners to advance product development, conduct clinical studies, and scale manufacturing for broader market delivery. Users of its technology include product developers, nutrition brands, and animal health stakeholders seeking science-based gut health solutions. Bactolife continues to expand its ingredient offerings and global deployment of its Binding Protein platform to address emerging health and microbiome needs.